Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications - Wikidata - awgldk - TriplyDB

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

http://www.wikidata.org/entity/Q37760962

about

High-risk corneal allografts: A therapeutic challenge Neuromuscular Regeneration: Perspective on the Application of Mesenchymal Stem Cells and Their Secretion Products The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis Allogenic banking of dental pulp stem cells for innovative therapeutics Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update Stem cells for the treatment of musculoskeletal pain Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditions Immunotherapeutic potential of extracellular vesicles Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications Improving the safety of tolerance induction: chimerism and cellular co-treatment strategies applied to vascularized composite allografts.Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches Modulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHD Mesenchymal Stem Cells Regulate the Innate and Adaptive Immune Responses Dampening Arthritis Progression Resveratrol as a natural anti-tumor necrosis factor-α molecule: implications to dendritic cells and their crosstalk with mesenchymal stromal cells Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.Pathogenic or Therapeutic Extracellular Vesicles in Rheumatic Diseases: Role of Mesenchymal Stem Cell-Derived Vesicles.Identification of a common reference gene pair for qPCR in human mesenchymal stromal cells from different tissue sources treated with VEGF Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia.Stem Cell Therapy: A New Treatment for Burns?IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis Granulocyte-Colony Stimulating Factor (G-CSF) Accelerates Wound Healing in Hemorrhagic Shock Rats by Enhancing Angiogenesis and Attenuating Apoptosis.Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy.Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.Generation and characterization of an immortalized human mesenchymal stromal cell line.Secretion of immunoregulatory cytokines by mesenchymal stem cells.Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations.Local delivery of mesenchymal stem cells with poly-lactic-co-glycolic acid nano-fiber scaffold suppress arthritis in rats Identification of miR-27b as a novel signature from the mRNA profiles of adipose-derived mesenchymal stem cells involved in the tolerogenic response Effect of DiD Carbocyanine Dye Labeling on Immunoregulatory Function and Differentiation of Mice Mesenchymal Stem Cells.Amniotic fluid stem cells with low γ-interferon response showed behavioral improvement in Parkinsonism rat model.Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.Promoting the recovery of injured liver with poly (3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) scaffolds loaded with umbilical cord-derived mesenchymal stem cells.Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.Mesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue?Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.Biomineralized hydroxyapatite nanoclay composite scaffolds with polycaprolactone for stem cell-based bone tissue engineering.CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus.In vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells.

P2860

Q26751483-EA444CA4-60E1-49AE-A0FC-5703FB40FB3F Q26765840-09451D3B-D700-45A0-AFBD-C477A35855D5 Q26773017-FC50E55D-223B-4B16-B313-EE21F08DAF11 Q26795542-09B0C53D-6E40-4615-8AA7-33ADB7C70340 Q26798145-37BE23F8-DD7C-4350-B3B1-E56CD9CF7770 Q26830679-E1314572-A2ED-47E7-97F4-2619A4743CFB Q26852836-B912A540-441B-48F3-86E7-7D2F106B95D2 Q27023323-7FE7B54C-50A4-4236-85C1-86FB51E2D80B Q27026892-9D9E5081-11CF-4FC5-A3A7-D0847D6AA707 Q27690246-563A6B29-252B-4912-A079-A8E1CF574FFF Q28072449-C83C270D-108F-428A-8F8C-A93C06C23BE6 Q28077242-A542F3DE-0DB8-4596-8B17-0DD634FBF0CA Q28078360-0565C04B-FDF1-4C8B-8D25-F73D819F0BFC Q28540693-92766602-6E6D-4A92-9B2E-FFF0D5BE04DD Q29994669-29845C8F-9DFB-49B5-8FA0-B962EF847778 Q30736517-A2B5AE69-DEDF-46BD-9464-1459F6E572FC Q31101562-1467F947-F9FB-42D0-AB25-E005D8E3CCA6 Q33625006-DB77474C-0627-42AC-9BD1-43104C3B2E5B Q33712440-6217BF09-BA49-4887-9213-B43DD98BC70A Q33759539-EA5ACA5A-4DD9-4447-B829-98D4D0E43CFC Q33765265-CA63468C-DCB1-4A43-B892-B88179BEBDE6 Q33769303-A8DD00B6-D7E7-4D70-941B-1F802C4F7B73 Q33772176-7ACA3316-164B-4EC1-A465-75971BCB62E6 Q33808890-C4B0FF19-2303-486D-9F82-FC0F11B12D7C Q34131746-FB420213-AD77-4258-AD75-405D484649AF Q34231344-EDDDF254-C48D-4A6C-BD0B-A336B42F1125 Q34259098-84AC6B58-C017-4A9B-A389-2682E6277860 Q34563072-077D8443-664E-48CF-B163-4D03B2DC6198 Q34634748-574F5154-B398-4C18-974E-A8456F5934E9 Q34683676-19E49D33-C77C-48E7-AAA3-B7E71740628D Q34785710-775060E5-E815-4991-A1E7-B0C7FEF7B588 Q35010233-02268332-E4DE-43E4-A359-A0E6F1AEE088 Q35038567-F8C29DB5-06A9-42B8-A36C-D83C7C0D4058 Q35097787-EA26E038-2333-405F-A819-19289744BD52 Q35100235-0C6634DD-4184-4703-9F66-629C0D496751 Q35155191-1907DECE-754D-48BB-BEDA-9FE62A88E5CE Q35203695-5AE412CA-2090-494B-B4C3-5205BC915F93 Q35352327-DBDE7EF1-25B2-491C-8108-F25716EDF98D Q35562294-BC42E925-43D7-496A-83CD-1DF094053628 Q35759033-CDD9BBD5-1E2F-436A-9B4B-C11EFC74D7F7

P2860

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

http://www.wikidata.org/entity/Q37760962

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

@en

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

@nl

type

label

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

@en

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

@nl

prefLabel

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

@en

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

@nl

P1433

Q37760962-6E7107B3-4E08-4465-BCFA-B94A54B05E18

P1476

Q37760962-F86D8148-0583-4470-81F6-D48C388F63C0

P2093

Q37760962-09810379-41BC-4D45-AB19-0225655BF336

Q37760962-727AEE01-CFEC-4A1C-A00A-D451B404E816

Q37760962-C34483C1-9841-48A7-AAE9-E95BE6748CF3

Q37760962-E8094FD3-1605-4D51-873B-B058479754BC

Q37760962-FBCC448B-51AB-44E8-BE7B-4FE744A7F5F4

P2860

Q37760962-0C56FC4E-7E3A-4179-9EE6-5EC4F2EDAE1D

Q37760962-0F1BBBEF-005C-4C9F-82E3-26EF642544CB

Q37760962-106C69B7-FD88-4ADE-834A-4B47F391EDCE

Q37760962-120ACA4D-D952-425A-9F91-DCB8F13A2AD9

Q37760962-1D614AC4-BFE3-4387-8563-5AEB6EABC373

Q37760962-27F7787E-7E0F-4C93-837F-5A74EE5567A2

Q37760962-2A4FE749-0E5E-410C-877A-05EB9F7D639A

Q37760962-2F212AF9-8966-4666-AE69-FFAA6252D938

Q37760962-314990F4-520C-4CBA-A523-160A52FFA1BC

Q37760962-36B73D21-11AE-461E-90B8-2D375BC34494

P2888

Q37760962-5DB987CE-8F43-4531-A2B4-2383FAE437B0

P304

Q37760962-92E96E41-1C31-49A8-AD2C-EB7FD4F050F6

P31

Q37760962-424C6C1A-0E69-4BEE-9517-2340FCBDC62F

P356

Q37760962-F25FCA6E-B37A-44C2-8AA3-9FE46593FC24

P433

Q37760962-2AC998A6-9B5D-4D6C-A60B-E026E9568FB3

P478

Q37760962-BF69D698-18A5-4373-9C30-A50536809EFC

P577

Q37760962-D0D7059D-9FC7-4DA9-984F-7CCEAA35235C

P5875

Q37760962-ECA19C66-1017-448E-A4D2-016B90961954

P6179

Q37760962-7EF240A1-6420-49F2-B04A-B7D946D8C367

P698

Q37760962-4433F80E-F85A-4909-8879-B62E9D2FA2F9

P921

Q37760962-B0B30326-1357-45E9-B8AD-0517443C905B

P932

Q37760962-D0AC7E21-4658-48B8-AA66-1CD037AEC44E

P356

P1433

Stem Cell Research & Therapy

P1476

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

@en

P2093

Carine Bouffi

http://www.w3.org/2001/XMLSchema#string

Christian Jorgensen

http://www.w3.org/2001/XMLSchema#string

Danièle Noël

http://www.w3.org/2001/XMLSchema#string

Farida Djouad

http://www.w3.org/2001/XMLSchema#string

Soufiane Ghannam

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

Multilineage potential of adult human mesenchymal stem cells

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique

Human mesenchymal stem cells modulate allogeneic immune cell responses

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Mesenchymal stem cells reside in virtually all post-natal organs and tissues

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

P2888

P304

2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/SCRT2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44632011

http://www.w3.org/2001/XMLSchema#string

P6179

1042902668

http://www.w3.org/2001/XMLSchema#string

P698

20504283

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

2873698

http://www.w3.org/2001/XMLSchema#string